Frontiers in Pharmacology | Neuropharmacology

Original Research

Published on 22 Apr 2025

GluN2B influences the progression of status epilepticus by modulating calcium ion homeostasis through its interaction with CaMKIIα

in Neuropharmacology

Lin Zhang
Youshi Meng
Chaoning Liu
Lei Wei
Yuling Lu
Shouhuan Zheng
Donghua Zou
Yuan Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1550879

Systematic Review

Published on 22 Apr 2025

Curcumin as a potential therapeutic agent for Parkinson’s disease: a systematic review

in Neuropharmacology

Yu-Hsien Chang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1593191

146 views

Review

Accepted on 21 Apr 2025

Progress in the study of the effects of selective serotonin reuptake inhibitors (SSRIs) on the reproductive system

in Neuropharmacology

Yu Feng
Xiaoyan Qu
Hua Hao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1567863

Original Research

Accepted on 21 Apr 2025

Antidepressant-like activity of Bezafibrate in mice models of depression: A behavioral and neurobiological characterization

in Neuropharmacology

Dawei Xu
Jin Zhou
Siyi Zhou
Weizhen Wang
Chengniu Wang
Bo Jiang
Wei Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1595341

Original Research

Accepted on 21 Apr 2025

Protective Effect of Brain Microvascular Endothelial Cell-Derived Exosomes on Blood-Brain Barrier Induced by Ischemia-Reperfusion Injury in vivo and in vitro

in Neuropharmacology

Jin Sun
Meng Wang
Lichen Guo
Yushuang Cao
Linlin Su
Shaoxia Wang
Lijuan Chai
Qing Yuan
Hulimin Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548122

Case Report

Accepted on 21 Apr 2025

Case Report: Linezolid-associated Toxic Optic Neuropathy in Patients with Pulmonary Tuberculosis: Case series and Mini Review

in Neuropharmacology

Hee Jin Yun
Su Jin Kim
Gwang Eon Han
Eun Jung Choi
Ji-Eun Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547236

Original Research

Accepted on 21 Apr 2025

Association of Serum Insulin-like Growth Factor-1 and Adrenocorticotropic Hormone Therapeutic Response in Patients with Infantile Epileptic Spasms Syndrome

in Neuropharmacology

Ka-Na Lin
Feng Han
Ying-Yan Wang
Wei Zhao
Ji-Wen Wang
Hao Li
YUNQING ZHOU

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1599641

Original Research

Accepted on 16 Apr 2025

Administration of chiglitazar reverses chronic stress-induced depressive-like symptoms in mice via activation of hippocampal PPARα and BDNF

in Neuropharmacology

Jiu-Jian Zhou
Jie Zhao
Shang-Yan Gao
Yuan-Yuan Gao
Cheng Chen
Yi Ding
Zhonghua Wu
Pu-jian Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1587399

Mini Review

Accepted on 16 Apr 2025

Trace amine-associated receptors as potential targets for the treatment of anxiety and depression

in Neuropharmacology

Zelong Li
Luoting Wan
Jing Dong
Jinquan Li
Jianfeng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598048

Review

Published on 16 Apr 2025

Ginsenoside Rg1 in Parkinson’s disease: from basic research to clinical applications

in Neuropharmacology

Qianyan Wang
Lei Wei
Guanghui Chen
Qiang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1490480

203 views

Systematic Review

Published on 16 Apr 2025

Re-evaluation of the efficacy and safety of anti-Aβ monoclonal antibodies (lecanemab/donanemab) in the treatment of early Alzheimer’s disease

in Neuropharmacology

Haoyang Wang
Junying Pan
Mingming Zhang
Zengde Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1599048

286 views

Original Research

Published on 16 Apr 2025

Significant hindlimb static weight-bearing asymmetry persists for 40-weeks in a longitudinal study in two widely used rat models of surgically induced osteoarthritis knee pain

in Neuropharmacology

A. Kuo
A. Raboczyj
J. R. Nicholson
L. Corradini
M. T. Smith

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1560265

163 views

Review

Accepted on 15 Apr 2025

Potential Therapeutic Targets for Ischemic Stroke in Pre-clinical Studies: Epigenetic-Modifying Enzymes DNMT/TET and HAT/HDAC

in Neuropharmacology

Yurou Guo
Jing Li
Xiaodan Liu
Huang Ding
Wei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571276

120 views

Mini Review

Accepted on 14 Apr 2025

The role of glutamate dehydrogenase in the ageing brain

in Neuropharmacology

Tao Zhou
Haichuan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586655

Review

Accepted on 14 Apr 2025

Current insights and prospects for the pathogenesis and treatment of clinical manifestations associated with Down syndrome through neurotransmitter, inflammatory, and oxidative stress pathways

in Neuropharmacology

Fawaz Alasmari
Ashfaq Ahmad
Sary Alsanea
Alaa Hammad
Walid Al-Qerem

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1592277

Systematic Review

Accepted on 14 Apr 2025

Effectiveness and Safety of Single Anti-Seizure Medication as Adjunctive Therapy for Drug-Resistant Focal Epilepsy based on Network Meta-Analysis

in Neuropharmacology

Nian-Jia Deng
Zhixin Zhang
Chen-Yang Xian-Yu
Yu-Ting Tao
Yu-Tong Ma
Hui-Jun Li
Teng-Yu Gao
Xin Liu
Jie Luo
Chao Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1500475